NO20034972L - Behandling av ADHD - Google Patents

Behandling av ADHD

Info

Publication number
NO20034972L
NO20034972L NO20034972A NO20034972A NO20034972L NO 20034972 L NO20034972 L NO 20034972L NO 20034972 A NO20034972 A NO 20034972A NO 20034972 A NO20034972 A NO 20034972A NO 20034972 L NO20034972 L NO 20034972L
Authority
NO
Norway
Prior art keywords
adhd
treatment
Prior art date
Application number
NO20034972A
Other languages
English (en)
Other versions
NO20034972D0 (no
Inventor
Klaus Peter Hertel
Joern Arnt
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20034972D0 publication Critical patent/NO20034972D0/no
Publication of NO20034972L publication Critical patent/NO20034972L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
NO20034972A 2001-05-09 2003-11-07 Behandling av ADHD NO20034972L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100732 2001-05-09
PCT/DK2002/000298 WO2002089797A1 (en) 2001-05-09 2002-05-07 Treatment of adhd

Publications (2)

Publication Number Publication Date
NO20034972D0 NO20034972D0 (no) 2003-11-07
NO20034972L true NO20034972L (no) 2003-11-07

Family

ID=8160484

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034972A NO20034972L (no) 2001-05-09 2003-11-07 Behandling av ADHD

Country Status (23)

Country Link
US (1) US7294638B2 (no)
EP (1) EP1387682A1 (no)
JP (1) JP2004528361A (no)
KR (1) KR20040007544A (no)
CN (1) CN1507351A (no)
AR (1) AR033287A1 (no)
BG (1) BG108400A (no)
BR (1) BR0209443A (no)
CA (1) CA2446652A1 (no)
CO (1) CO5540378A2 (no)
CZ (1) CZ20033197A3 (no)
EA (1) EA200301221A1 (no)
HR (1) HRP20030852A2 (no)
HU (1) HUP0400075A2 (no)
IL (1) IL158413A0 (no)
IS (1) IS6992A (no)
MX (1) MXPA03010136A (no)
NO (1) NO20034972L (no)
NZ (1) NZ528896A (no)
PL (1) PL367778A1 (no)
SK (1) SK15002003A3 (no)
WO (1) WO2002089797A1 (no)
ZA (1) ZA200307955B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003102097A1 (en) * 2002-05-31 2003-12-11 H. Lundbeck A/S The hydrochloride of (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole
WO2006047330A2 (en) * 2004-10-22 2006-05-04 Mark Froimowitz Methylphenidate analogs and methods of use thereof
WO2009136410A2 (en) 2008-04-19 2009-11-12 Nisarga Biotech Pvt. Ltd. Herbal composition for reducing add/adhd and method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521197A (en) 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives
WO2002046156A2 (en) * 2000-12-06 2002-06-13 Sepracor, Inc. 4,4-disubstituted piperidines for use as dopamine, serotonin and norepinephrine ligands

Also Published As

Publication number Publication date
HUP0400075A2 (hu) 2004-04-28
NO20034972D0 (no) 2003-11-07
BG108400A (bg) 2004-11-30
CN1507351A (zh) 2004-06-23
KR20040007544A (ko) 2004-01-24
HRP20030852A2 (en) 2005-06-30
JP2004528361A (ja) 2004-09-16
NZ528896A (en) 2004-12-24
EP1387682A1 (en) 2004-02-11
PL367778A1 (en) 2005-03-07
CA2446652A1 (en) 2002-11-14
EA200301221A1 (ru) 2004-04-29
MXPA03010136A (es) 2004-03-10
IS6992A (is) 2003-10-13
CZ20033197A3 (en) 2004-06-16
US7294638B2 (en) 2007-11-13
US20040152737A1 (en) 2004-08-05
ZA200307955B (en) 2004-10-13
AR033287A1 (es) 2003-12-10
CO5540378A2 (es) 2005-07-29
IL158413A0 (en) 2004-05-12
WO2002089797A1 (en) 2002-11-14
BR0209443A (pt) 2004-08-03
SK15002003A3 (sk) 2004-05-04
WO2002089797A8 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20035156L (no) Fremgangsmåter for brønnbehandling
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
ATE381347T1 (de) Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
DE60217317D1 (de) Wärmebehandlungsverfahren
DE60218451D1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
DE60200578D1 (de) Ozonsterilisationsverfahren
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
NO20033804D0 (no) Karbamatforbindelser for behandling av smerte
NO20041968L (no) Anvendelse av cystationin
NO334788B2 (no) Fremgangsmåte for behandling av søvnløshet
NO20024236D0 (no) Behandling av psoriasis
SE0301854L (sv) Antiigensättningsbehandling
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
DE60103685D1 (de) Behandlung von Poriomania
GB0124124D0 (en) Methods of treatment
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
NO20043113L (no) Fremgangsmate for behandling av benforstyrrelse
NO20034972D0 (no) Behandling av ADHD
ATE333439T1 (de) Pflanzenkläranlage
NO20030767L (no) Behandling av forbrenninger
NO20025765L (no) Kombinasjonssett for behandling av malaria
SE0104249D0 (sv) Method of treatment
NO20033160D0 (no) Anordning for behandling av gravann
NO20010171D0 (no) Teknisk behandling av tåke

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application